The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMan Regulatory News (EMG)

Share Price Information for Man (EMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 262.60
Bid: 262.60
Ask: 263.00
Change: 1.60 (0.61%)
Spread: 0.40 (0.152%)
Open: 258.80
High: 263.00
Low: 258.80
Prev. Close: 261.00
EMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Dividend - Sterling Conversion Rate

1 Sep 2023 09:30

RNS Number : 1116L
Man Group plc
01 September 2023
 

Interim Dividend - Pence Sterling Amount Payable

 

Man Group plc (the "Company") announced on 1 August 2023, an interim dividend for the year ending 31 December 2023 of 5.6 US cents per ordinary share and communicated that the corresponding amount in Pence Sterling per ordinary share would be announced on 1 September 2023. The Pence Sterling amount payable in respect of the interim dividend has been determined with reference to the average of the market exchange rates on the three working days commencing 29 August 2023, resulting in an applicable exchange rate of £1:US$1.26608. Accordingly, the Pence Sterling amount payable to Shareholders in relation to the interim dividend will be 4.42 pence per ordinary share.

 

The interim dividend will be paid on 22 September 2023 to shareholders on the register at the close of business on 11 August 2023.

 

 

Enquiries

 

Karan ShirgaokarDirector, Investor Relations+44 (0)20 7144 1434 investor.relations@man.com

 

Elizabeth Woods

Company Secretary

+44 20 7144 1733

company.secretarial@man.com

Danny Read

Communications Manager

+44 20 7144 1000

communications@man.com  

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVGIGDCRGGDGXB
Date   Source Headline
29th Sep 20216:05 pmRNSTransaction in Own Shares
28th Sep 20216:07 pmRNSTransaction in Own Shares
27th Sep 20215:50 pmRNSTransaction in Own Shares
24th Sep 20216:06 pmRNSTransaction in Own Shares
23rd Sep 20215:49 pmRNSTransaction in Own Shares
22nd Sep 202110:13 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
22nd Sep 202110:06 amGNWMan Group PLC : Form 8.3 - John Laing Group plc
21st Sep 20215:47 pmRNSTransaction in Own Shares
21st Sep 20219:19 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
20th Sep 20215:41 pmRNSTransaction in Own Shares
17th Sep 20215:54 pmRNSTransaction in Own Shares
17th Sep 20213:00 pmRNSDirectorate Change
16th Sep 20215:52 pmRNSTransaction in Own Shares
15th Sep 20216:16 pmRNSTransaction in Own Shares
15th Sep 202111:14 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
14th Sep 20215:52 pmRNSTransaction in Own Shares
14th Sep 20211:56 pmRNSMan Group PLC : Form 8.3 - Strongbridge biopharma plc
13th Sep 20215:51 pmRNSTransaction in Own Shares
13th Sep 202112:15 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
13th Sep 202112:06 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
10th Sep 20215:55 pmRNSTransaction in Own Shares
10th Sep 20217:21 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
9th Sep 20215:58 pmRNSTransaction in Own Shares
9th Sep 202111:40 amRNSDirector/PDMR Shareholding
9th Sep 20216:56 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
8th Sep 20215:53 pmRNSTransaction in Own Shares
8th Sep 20214:25 pmRNSDirector/PDMR Shareholding
8th Sep 20217:15 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
7th Sep 20215:54 pmRNSTransaction in Own Shares
3rd Sep 20215:47 pmRNSTransaction in Own Shares
3rd Sep 20217:58 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
3rd Sep 20217:02 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
2nd Sep 20215:56 pmRNSTransaction in Own Shares
2nd Sep 20216:59 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
2nd Sep 20216:48 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
1st Sep 20215:54 pmRNSTransaction in Own Shares
1st Sep 20217:21 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
1st Sep 20217:06 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
1st Sep 20217:00 amRNSTotal Voting Rights
31st Aug 20216:02 pmRNSTransaction in Own Shares
31st Aug 20217:47 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
31st Aug 20217:22 amGNWMan Group PLC : Form 8.3 - Stonebridge Biopharma plc
30th Aug 20217:22 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
27th Aug 20215:41 pmRNSTransaction in Own Shares
27th Aug 20218:20 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
26th Aug 20215:35 pmRNSTransaction in Own Shares
26th Aug 202110:18 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
25th Aug 20215:47 pmRNSTransaction in Own Shares
25th Aug 202112:59 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
25th Aug 202112:54 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.